BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
AGREEMENTS: Name Products Content of Agreement Date
Arch Pharmalabs use of
research and 10/05
Ltd.
MolecularBreeding manufacturing
technology in
manufacturing
compound
agreement
Bristol-Myers pharmaceutical process research
5/05
Squibb Co. research
agreement,
extended 1/06
Cargill Dow LLC novel synthesis for development 2002
Cargill Dow's
NatureWorks PLA
(polylactide)
agreement
Chevron
novel bioprocesses for three-year
10/02
Research and specific petrochemical development
Technology Co. products
agreement
Eli Lilly & Co. improved fermentations development 12/02
for Lilly’s natural
product drugs
agreement
Gist-brocades NV development of novel three-year research 3/99
(subsidiary of enzymes for the and licensing
DSM NV)
manufacture of penicillin
antibiotics
agreement
Matrix
API for a high-value development and 6/05
Laboratories Ltd. pharmaceutical product commercialization
agreement
Novozymes development and bulk five-year strategic 9/97
production of specific
industrial enzymes in
fields of laundry
detergents, leather
processing and pulp
and paper
manufacturing, among
others
collaboration
Pfizer Inc. biochemical
extension of 5/98 9/00
manufacturing of
undislcosed
pharmaceutical product
agreement
Pfizer Inc. pharmaceutical life
cycle management
R&D agreement 7/04
Sandoz process for the
production of a key
fermented active
pharmaceutical
Schering-Plough
Corp.
Shasun
Chemicals and
Drugs Limited
Teva
Pharmaceutical
Industries Ltd.
compound of Sandoz
development of a
synthetic process for
Schering-Plough
pharmaceutical
intermediate for a
generic drug
improved processes for
manufacturing of an
undisclosed
pharmaceutical product
using Codexis'
MolecularBreeding
directed evolution
platform
development
agreement
research
agreement
manufacturing and
supply agreement
research
collaboration
agreement
Copyright ©2006 AHC Media ® 118
10/03
3/06
5/05
12/04